about
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the pote...
Read More
4.70
-0.33
(-6.56%)
1.2M
XNAS Volume
XNAS 12 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Climb Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..